FIVE‐AMINOLEVULINIC ACID FOR FLUORESCENCE‐GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS: A PHASE II STUDY
暂无分享,去创建一个
Arya Nabavi | Heinrich Lanfermann | Uwe Pichlmeier | Maximilian Mehdorn | H. Lanfermann | A. Nabavi | M. Mehdorn | U. Pichlmeier | T. Pietsch | Holger Thurm | Basilios Zountsas | Thorsten Pietsch | Basilios Zountsas | H. Thurm
[1] A. Nabavi,et al. Awake Craniotomy and Intraoperative Magnetic Resonance Imaging: Patient Selection, Preparation, and Technique , 2008, Topics in magnetic resonance imaging : TMRI.
[2] J. Markert,et al. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] J. Perry,et al. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule , 2008, Cancer.
[4] M. Ruge,et al. Intraoperative mapping of language functions: a longitudinal neurolinguistic analysis. , 2008, Journal of neurosurgery.
[5] H. Duffau,et al. Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere. , 2008, Journal of neurosurgery.
[6] Sachio Suzuki,et al. Auditory alert system for fluorescence-guided resection of gliomas. , 2008, Neurologia medico-chirurgica.
[7] Walter A Hall,et al. Intraoperative MR‐guided neurosurgery , 2008, Journal of magnetic resonance imaging : JMRI.
[8] N. Tandon,et al. Intraoperative subcortical language tract mapping guides surgical removal of gliomas involving speech areas , 2008 .
[9] Sachio Suzuki,et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. , 2007, Neurologia medico-chirurgica.
[10] Hong Liu,et al. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. , 2007, International journal of radiation oncology, biology, physics.
[11] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[12] Y. Kajita,et al. Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma , 2006, Brain Tumor Pathology.
[13] Z. Ram,et al. Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial , 2006, Acta Neurochirurgica.
[14] J. Debus,et al. Stereotactic radiosurgery (SRS) , 2005, Cancer.
[15] Hans-Jakob Steiger,et al. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. , 2005, Journal of neurosurgery.
[16] Susan M. Chang,et al. Temozolomide in the treatment of recurrent malignant glioma , 2004, Cancer.
[17] O Ganslandt,et al. Functional neuronavigation and intraoperative MRI. , 2004, Advances and technical standards in neurosurgery.
[18] W. Shapiro,et al. Intra-arterial Cisplatin Plus Oral Etoposide for the Treatment of Recurrent Malignant Glioma: A Phase II Study , 2004, Journal of Neuro-Oncology.
[19] M. Pomper,et al. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging. , 2003, AJR. American journal of roentgenology.
[20] W. Stummer,et al. Transport of 5-aminolevulinic acid between blood and brain , 2003, Brain Research.
[21] S. Kunwar. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. , 2003, Acta neurochirurgica. Supplement.
[22] H. Aydin,et al. Patterns of Failure Following CT-Based 3-D Irradiation for Malignant Glioma , 2001, Strahlentherapie und Onkologie.
[23] M Molls,et al. A comparison of treatment results for recurrent malignant gliomas. , 2000, Cancer treatment reviews.
[24] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.
[25] D. Frappaz,et al. Is reoperation for recurrence of glioblastoma justified? , 2000, Oncology reports.
[26] W. Stummer,et al. Mechanisms of 5‐Aminolevulinic Acid Uptake at the Choroid Plexus , 2000, Journal of neurochemistry.
[27] P. V. van Rijk,et al. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study. , 1999, Nuclear medicine communications.
[28] W. Stummer,et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.
[29] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.
[30] W. Stummer,et al. Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue , 1998, Acta Neurochirurgica.
[31] P. Wen,et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. , 1995, Neurosurgery.
[32] M. Bernstein,et al. The value of reoperation for recurrent glioblastoma. , 1993, Canadian journal of surgery. Journal canadien de chirurgie.
[33] N. Vick,et al. Reoperation for malignant astrocytoma , 1989, Neurology.
[34] M. Ammirati,et al. Reoperation in the treatment of recurrent intracranial malignant gliomas. , 1987, Neurosurgery.
[35] S. Ronner,et al. Cortical mapping for defining the limits of tumor resection. , 1987, Neurosurgery.